BUD
Anheuser-Busch InBev SA/NV
Beverages - Alcoholic
Market Cap$138.11B
5Y Perf.+71.2%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
BUD vs ABEV
Revenue, margins, valuation, and 5-year total return — side by side.
ABEV
Ambev S.A.
Beverages - Alcoholic
Market Cap$51.07B
5Y Perf.+41.6%
BUD vs ABEV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | BUD | ABEV |
|---|---|---|
| Industry | Beverages - Alcoholic | Beverages - Alcoholic |
| Market Cap | $138.11B | $51.07B |
| Revenue (TTM) | $119.82B | $88.21B |
| Net Income (TTM) | $12.57B | $15.58B |
| Gross Margin | 55.2% | 51.5% |
| Operating Margin | 31.7% | 27.2% |
| Forward P/E | 18.8x | 3.2x |
| Total Debt | $72.17B | $5.35B |
| Cash & Equiv. | $11.17B | $18.64B |
BUD vs ABEV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
BUD
ABEV
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Anheuser-Busch InBe… (BUD) | 100 | 171.2 | +71.2% |
| Ambev S.A. (ABEV) | 100 | 141.6 | +41.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BUD vs ABEV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: ABEV leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Anheuser-Busch InBev SA/NV is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
BUD
Anheuser-Busch InBev SA/NV
The Growth Play
BUD is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 0.7%, EPS growth 10.0%, 3Y rev CAGR 3.2%
- Lower volatility, beta 0.28, Low D/E 81.4%, current ratio 0.70x
- 0.7% revenue growth vs ABEV's -1.4%
Best for: growth exposure and sleep-well-at-night
ABEV
Ambev S.A.
The Income Pick
ABEV carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.43, yield 8.1%
- -14.2% 10Y total return vs BUD's -24.5%
- Beta 0.43, yield 8.1%, current ratio 0.96x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | BUD | 0.7% revenue growth vs ABEV's -1.4% |
| Value | ABEV | Lower P/E (3.2x vs 18.8x) |
| Quality / Margins | ABEV | 17.7% margin vs BUD's 10.5% |
| Stability / Safety | BUD | Beta 0.28 vs ABEV's 0.43 |
| Dividends | ABEV | 8.1% yield, 1-year raise streak, vs BUD's 1.6% |
| Momentum (1Y) | ABEV | +38.0% vs BUD's +24.5% |
| Efficiency (ROA) | ABEV | 10.9% ROA vs BUD's 6.0%, ROIC 22.3% vs 7.5% |
BUD vs ABEV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2020
Segment breakdown not available.
BUD vs ABEV — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLABEVLAGGINGBUD
BUDAnheuser-Busch InBev …
2leads
ABEVAmbev S.A.
3leads
6 Total Categories
CATEGORYLEADERvs BUDMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
BUD5/6
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ABEV8/9
Total Returns1Y, 3Y, 5Y total returns with dividends
ABEV6/6
Risk & VolatilityBeta, volatility, and downside exposure
BUD2/2
Analyst OutlookRatings, price targets, and dividends
ABEV2/2
Income & Cash Flow (Last 12 Months)
BUD leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BUD and ABEV operate at a comparable scale, with $119.8B and $88.2B in trailing revenue. ABEV is the more profitable business, keeping 17.7% of every revenue dollar as net income compared to BUD's 10.5%.
| Metric | BUDAnheuser-Busch In… | ABEVAmbev S.A. |
|---|---|---|
| RevenueTrailing 12 months | $119.8B | $88.2B |
| EBITDAEarnings before interest/tax | $38.8B | $30.7B |
| Net IncomeAfter-tax profit | $12.6B | $15.6B |
| Free Cash FlowCash after capex | $32.2B | $22.2B |
| Gross MarginGross profit ÷ Revenue | +55.2% | +51.5% |
| Operating MarginEBIT ÷ Revenue | +31.7% | +27.2% |
| Net MarginNet income ÷ Revenue | +10.5% | +17.7% |
| FCF MarginFCF ÷ Revenue | +26.9% | +25.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.4% | -0.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +32.3% | +4.3% |
BUD leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
Evenly matched — BUD and ABEV each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 16.4x trailing earnings, ABEV trades at a 42% valuation discount to BUD's 28.1x P/E. On an enterprise value basis, ABEV's 8.2x EV/EBITDA is more attractive than BUD's 9.5x.
| Metric | BUDAnheuser-Busch In… | ABEVAmbev S.A. |
|---|---|---|
| Market CapShares × price | $138.1B | $51.1B |
| Enterprise ValueMkt cap + debt − cash | $199.1B | $48.4B |
| Trailing P/EPrice ÷ TTM EPS | 28.06x | 16.35x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.81x | 3.21x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.49x |
| EV / EBITDAEnterprise value multiple | 9.47x | 8.22x |
| Price / SalesMarket cap ÷ Revenue | 2.31x | 2.87x |
| Price / BookPrice ÷ Book value/share | 1.85x | 2.86x |
| Price / FCFMarket cap ÷ FCF | 12.34x | 12.73x |
Evenly matched — BUD and ABEV each lead in 3 of 6 comparable metrics.
Profitability & Efficiency
ABEV leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
ABEV delivers a 17.0% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $14 for BUD. ABEV carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to BUD's 0.81x. On the Piotroski fundamental quality scale (0–9), BUD scores 9/9 vs ABEV's 7/9, reflecting strong financial health.
| Metric | BUDAnheuser-Busch In… | ABEVAmbev S.A. |
|---|---|---|
| ROE (TTM)Return on equity | +13.8% | +17.0% |
| ROA (TTM)Return on assets | +6.0% | +10.9% |
| ROICReturn on invested capital | +7.5% | +22.3% |
| ROCEReturn on capital employed | +8.7% | +20.7% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 7 |
| Debt / EquityFinancial leverage | 0.81x | 0.06x |
| Net DebtTotal debt minus cash | $61.0B | -$13.3B |
| Cash & Equiv.Liquid assets | $11.2B | $18.6B |
| Total DebtShort + long-term debt | $72.2B | $5.3B |
| Interest CoverageEBIT ÷ Interest expense | 2.53x | 8.09x |
ABEV leads this category, winning 8 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
ABEV leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ABEV five years ago would be worth $12,626 today (with dividends reinvested), compared to $11,236 for BUD. Over the past 12 months, ABEV leads with a +38.0% total return vs BUD's +24.5%. The 3-year compound annual growth rate (CAGR) favors ABEV at 9.1% vs BUD's 8.4% — a key indicator of consistent wealth creation.
| Metric | BUDAnheuser-Busch In… | ABEVAmbev S.A. |
|---|---|---|
| YTD ReturnYear-to-date | +26.0% | +32.4% |
| 1-Year ReturnPast 12 months | +24.5% | +38.0% |
| 3-Year ReturnCumulative with dividends | +27.5% | +29.7% |
| 5-Year ReturnCumulative with dividends | +12.4% | +26.3% |
| 10-Year ReturnCumulative with dividends | -24.5% | -14.2% |
| CAGR (3Y)Annualised 3-year return | +8.4% | +9.1% |
ABEV leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
BUD leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BUD is the less volatile stock with a 0.28 beta — it tends to amplify market swings less than ABEV's 0.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | BUDAnheuser-Busch In… | ABEVAmbev S.A. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.28x | 0.43x |
| 52-Week HighHighest price in past year | $82.91 | $3.45 |
| 52-Week LowLowest price in past year | $56.97 | $2.10 |
| % of 52W HighCurrent price vs 52-week peak | +96.8% | +94.8% |
| RSI (14)Momentum oscillator 0–100 | 70.7 | 72.9 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 24.2M |
BUD leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
ABEV leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BUD as "Buy" and ABEV as "Hold". Consensus price targets imply 10.9% upside for BUD (target: $89) vs -13.1% for ABEV (target: $3). For income investors, ABEV offers the higher dividend yield at 8.06% vs BUD's 1.63%.
| Metric | BUDAnheuser-Busch In… | ABEVAmbev S.A. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $89.00 | $2.84 |
| # AnalystsCovering analysts | 45 | 14 |
| Dividend YieldAnnual dividend ÷ price | +1.6% | +8.1% |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | $1.31 | $1.30 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | +0.8% |
ABEV leads this category, winning 2 of 2 comparable metrics.
Key Takeaway
ABEV leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). BUD leads in 2 (Income & Cash Flow, Risk & Volatility). 1 tied.
Best OverallAmbev S.A. (ABEV)Leads 3 of 6 categories
Loading custom metrics...
BUD vs ABEV: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BUD or ABEV a better buy right now?
For growth investors, Anheuser-Busch InBev SA/NV (BUD) is the stronger pick with 0.
7% revenue growth year-over-year, versus -1. 4% for Ambev S. A. (ABEV). Ambev S. A. (ABEV) offers the better valuation at 16. 4x trailing P/E (3. 2x forward), making it the more compelling value choice. Analysts rate Anheuser-Busch InBev SA/NV (BUD) a "Buy" — based on 45 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BUD or ABEV?
On trailing P/E, Ambev S.
A. (ABEV) is the cheapest at 16. 4x versus Anheuser-Busch InBev SA/NV at 28. 1x. On forward P/E, Ambev S. A. is actually cheaper at 3. 2x.
03Which is the better long-term investment — BUD or ABEV?
Over the past 5 years, Ambev S.
A. (ABEV) delivered a total return of +26. 3%, compared to +12. 4% for Anheuser-Busch InBev SA/NV (BUD). Over 10 years, the gap is even starker: ABEV returned -14. 2% versus BUD's -24. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BUD or ABEV?
By beta (market sensitivity over 5 years), Anheuser-Busch InBev SA/NV (BUD) is the lower-risk stock at 0.
28β versus Ambev S. A. 's 0. 43β — meaning ABEV is approximately 55% more volatile than BUD relative to the S&P 500. On balance sheet safety, Ambev S. A. (ABEV) carries a lower debt/equity ratio of 6% versus 81% for Anheuser-Busch InBev SA/NV — giving it more financial flexibility in a downturn.
05Which is growing faster — BUD or ABEV?
By revenue growth (latest reported year), Anheuser-Busch InBev SA/NV (BUD) is pulling ahead at 0.
7% versus -1. 4% for Ambev S. A. (ABEV). On earnings-per-share growth, the picture is similar: Anheuser-Busch InBev SA/NV grew EPS 10. 0% year-over-year, compared to 8. 8% for Ambev S. A.. Over a 3-year CAGR, ABEV leads at 3. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BUD or ABEV?
Ambev S.
A. (ABEV) is the more profitable company, earning 17. 6% net margin versus 9. 8% for Anheuser-Busch InBev SA/NV — meaning it keeps 17. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BUD leads at 25. 9% versus 25. 3% for ABEV. At the gross margin level — before operating expenses — BUD leads at 55. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BUD or ABEV more undervalued right now?
On forward earnings alone, Ambev S.
A. (ABEV) trades at 3. 2x forward P/E versus 18. 8x for Anheuser-Busch InBev SA/NV — 15. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BUD: 10. 9% to $89. 00.
08Which pays a better dividend — BUD or ABEV?
All stocks in this comparison pay dividends.
Ambev S. A. (ABEV) offers the highest yield at 8. 1%, versus 1. 6% for Anheuser-Busch InBev SA/NV (BUD).
09Is BUD or ABEV better for a retirement portfolio?
For long-horizon retirement investors, Anheuser-Busch InBev SA/NV (BUD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
28), 1. 6% yield). Both have compounded well over 10 years (BUD: -24. 5%, ABEV: -14. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BUD and ABEV?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BUD is a mid-cap quality compounder stock; ABEV is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Net Margin>
%
(BUD: 10.5% · ABEV: 17.7%)P/E Ratio<
x
(BUD: 28.1x · ABEV: 16.4x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.